Search News

Corporate Industry Technology Medical Updates

Mechanical Circulatory Support

Corporate
magAssist's NyokAssist™ granted Designation by the FDA as a Breakthrough Device 2023-08-17
Corporate
BreathMo®: The New Generation ECMO system Revealed at ASAIO Conference 2023-07-22
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
magAssist Gains Recognition for Its Innovation in the Cardiovascular Field at 2022 Critical Heart Disease Congress-International Society for Mechanical Circulatory Support Parallel Forum 2023-01-16
Technology
2022 Critical Heart Disease Congress (CHDC·2022) | “BreathMo® - An Ultra-portable ECMO System” by Dr. Chia Hao Hsu from magAssist Inc. 2023-01-06
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12
Corporate
magAssist partners with top universities to help nurture young talents 2022-07-16
Corporate
magAssist was elected as the "2022 Future of Healthcare 100" 2022-06-17
Technology
magAssist is participating in 2022 EUMS-ISMCS joint conference. 2022-05-24

Tabs： membrane oxygenator, cardiac arrest, DonorLife Organ Care System, ECMO manufacturers, Fortune, left ventricular assist devices, multi-organ life support, Bridge-to-other destination therapy, Chronic heart failure, the new generation ECMO system,